264 related articles for article (PubMed ID: 19759515)
1. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice.
Hu Z; Wang H; Lee IH; Du J; Mitch WE
J Clin Invest; 2009 Oct; 119(10):3059-69. PubMed ID: 19759515
[TBL] [Abstract][Full Text] [Related]
2. Knockout of USP19 Deubiquitinating Enzyme Prevents Muscle Wasting by Modulating Insulin and Glucocorticoid Signaling.
Coyne ES; Bedard N; Wykes L; Stretch C; Jammoul S; Li S; Zhang K; Sladek RS; Bathe OF; Jagoe RT; Posner BI; Wing SS
Endocrinology; 2018 Aug; 159(8):2966-2977. PubMed ID: 29901692
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid Receptor Signaling Impairs Protein Turnover Regulation in Hypoxia-Induced Muscle Atrophy in Male Mice.
de Theije CC; Schols AMWJ; Lamers WH; Ceelen JJM; van Gorp RH; Hermans JJR; Köhler SE; Langen RCJ
Endocrinology; 2018 Jan; 159(1):519-534. PubMed ID: 29069356
[TBL] [Abstract][Full Text] [Related]
4. Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle.
Braun TP; Grossberg AJ; Krasnow SM; Levasseur PR; Szumowski M; Zhu XX; Maxson JE; Knoll JG; Barnes AP; Marks DL
FASEB J; 2013 Sep; 27(9):3572-82. PubMed ID: 23733748
[TBL] [Abstract][Full Text] [Related]
5. C1-Ten is a protein tyrosine phosphatase of insulin receptor substrate 1 (IRS-1), regulating IRS-1 stability and muscle atrophy.
Koh A; Lee MN; Yang YR; Jeong H; Ghim J; Noh J; Kim J; Ryu D; Park S; Song P; Koo SH; Leslie NR; Berggren PO; Choi JH; Suh PG; Ryu SH
Mol Cell Biol; 2013 Apr; 33(8):1608-20. PubMed ID: 23401856
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid-induced skeletal muscle atrophy.
Schakman O; Kalista S; Barbé C; Loumaye A; Thissen JP
Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading.
Nakao R; Hirasaka K; Goto J; Ishidoh K; Yamada C; Ohno A; Okumura Y; Nonaka I; Yasutomo K; Baldwin KM; Kominami E; Higashibata A; Nagano K; Tanaka K; Yasui N; Mills EM; Takeda S; Nikawa T
Mol Cell Biol; 2009 Sep; 29(17):4798-811. PubMed ID: 19546233
[TBL] [Abstract][Full Text] [Related]
8. Highly bioavailable Berberine formulation improves Glucocorticoid Receptor-mediated Insulin Resistance
Meng Z; Yu Y; Zhang Y; Yang X; Lv X; Guan F; Hatch GM; Zhang M; Chen L
Int J Biol Sci; 2020; 16(14):2527-2541. PubMed ID: 32792855
[TBL] [Abstract][Full Text] [Related]
9. Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: consequences on proteolysis.
Franch HA; Raissi S; Wang X; Zheng B; Bailey JL; Price SR
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F700-6. PubMed ID: 15161606
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PI3-kinase signaling by glucocorticoids results in increased branched-chain amino acid degradation in renal epithelial cells.
Wang X; Hu J; Price SR
Am J Physiol Cell Physiol; 2007 May; 292(5):C1874-9. PubMed ID: 17229808
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy.
Bailey JL; Zheng B; Hu Z; Price SR; Mitch WE
J Am Soc Nephrol; 2006 May; 17(5):1388-94. PubMed ID: 16611720
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling.
Kuo T; Lew MJ; Mayba O; Harris CA; Speed TP; Wang JC
Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11160-5. PubMed ID: 22733784
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting.
Mitch WE; Bailey JL; Wang X; Jurkovitz C; Newby D; Price SR
Am J Physiol; 1999 May; 276(5):C1132-8. PubMed ID: 10329962
[TBL] [Abstract][Full Text] [Related]
14. Muscle wasting from kidney failure-a model for catabolic conditions.
Wang XH; Mitch WE
Int J Biochem Cell Biol; 2013 Oct; 45(10):2230-8. PubMed ID: 23872437
[TBL] [Abstract][Full Text] [Related]
15. The crucial role of muscle glucocorticoid signaling in accelerating obesity and glucose intolerance via hyperinsulinemia.
Yamazaki H; Uehara M; Yoshikawa N; Kuribara-Souta A; Yamamoto M; Hirakawa Y; Kabe Y; Suematsu M; Tanaka H
JCI Insight; 2023 Apr; 8(8):. PubMed ID: 36917179
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling.
Wang X; Hu Z; Hu J; Du J; Mitch WE
Endocrinology; 2006 Sep; 147(9):4160-8. PubMed ID: 16777975
[TBL] [Abstract][Full Text] [Related]
17. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.
Langen RC; Gosker HR; Remels AH; Schols AM
Int J Biochem Cell Biol; 2013 Oct; 45(10):2245-56. PubMed ID: 23827718
[TBL] [Abstract][Full Text] [Related]
18. miR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle.
Agarwal P; Srivastava R; Srivastava AK; Ali S; Datta M
Biochim Biophys Acta; 2013 Aug; 1832(8):1294-303. PubMed ID: 23579070
[TBL] [Abstract][Full Text] [Related]
19. Des-aspartate-angiotensin-I and angiotensin IV improve glucose tolerance and insulin signalling in diet-induced hyperglycaemic mice.
Wong YC; Sim MK; Lee KO
Biochem Pharmacol; 2011 Nov; 82(9):1198-208. PubMed ID: 21803028
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
Tisdale MJ
J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
